Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM)

CUSIP: G6333L200

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Ordinary Shares, $0.01 par value per share
Shares outstanding
28,961,082
Total 13F shares
1,156,930
Share change
-1,142,357
Total reported value
$773,145
Price per share
$0.67
Number of holders
18
Value change
-$1,029,184
Number of buys
6
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP G6333L200?
CUSIP G6333L200 identifies ITRM - Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q3 2025

As of 30 Sep 2025, Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,156,930 shares. The largest 10 holders included Squarepoint Ops LLC, Apollon Financial, LLC, OneDigital Investment Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, Krilogy Financial LLC, Sanctuary Advisors, LLC, SG Americas Securities, LLC, JANE STREET GROUP, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 18 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.